Ignite Creation Date:
2024-05-06 @ 8:15 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06312670
Status:
RECRUITING
Last Update Posted:
2024-04-02
First Post:
2024-02-16
Brief Title:
Combining EPI-7386 with Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer
Sponsor:
Pedro Barata MD MSc
Organization:
Case Comprehensive Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-08-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-16
First Submit QC Date:
March 8 2024
Study First Post Date:
2024-03-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-19
Last Update Post Date:
2024-04-02
Last Update Post Date Type:
ACTUAL